There have been 50 recent insider transactions recorded for Apogee Therapeutics, Inc. (APGE), including 12 buys and 38 sells. Total insider buying was valued at $36.44M and total insider selling at $141.26M.
Notable insiders with recent activity include Henderson Jane, Dambkowski Carl, Henderson Michael Thomas. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — APGE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
1,100 |
$85.46 |
$94.01K |
177,371 |
| 2026-04-01 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
4,125 |
$22.86 |
$94.3K |
127,165 |
| 2026-03-25 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
2,000 |
$85.00 |
$170K |
179,371 |
| 2026-03-11 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
3,418 |
$75.86 |
$259.29K |
1,152,987 |
| 2026-03-04 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
4,125 |
$22.86 |
$94.3K |
131,290 |
| 2026-03-02 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
406 |
$71.66 |
$29.09K |
181,371 |
| 2026-02-11 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
955 |
$64.99 |
$62.07K |
1,172,987 |
| 2026-02-04 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
4,125 |
$22.86 |
$94.3K |
135,415 |
| 2026-02-02 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
100 |
$66.89 |
$6.69K |
183,371 |
| 2026-01-22 |
Fairmount Funds Management Llc |
Director |
Informative Sell |
1,750,000 |
$76.30 |
$133.53M |
298,647 |
| 2026-01-14 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
470 |
$83.79 |
$39.38K |
1,192,987 |
| 2026-01-07 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
14,025 |
$22.86 |
$320.61K |
139,540 |
| 2026-01-06 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
2,000 |
$80.00 |
$160K |
185,371 |
| 2026-01-02 |
Henderson Jane |
Chief Financial Officer |
RSU Award |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2026-01-02 |
Henderson Michael Thomas |
Chief Executive Officer |
RSU Award |
253,016 |
$75.78 |
$19.17M |
253,016 |
| 2026-01-02 |
Dambkowski Carl |
Chief Medical Officer |
RSU Award |
83,690 |
$75.78 |
$6.34M |
83,690 |
| 2025-12-19 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
1,500 |
$80.00 |
$120K |
193,371 |
| 2025-12-10 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
560 |
$76.58 |
$42.88K |
1,212,987 |
| 2025-12-04 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
1,500 |
$75.00 |
$112.5K |
194,871 |
| 2025-12-04 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
40,000 |
$75.01 |
$3M |
1,232,987 |
| 2025-12-04 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
10,900 |
$75.00 |
$817.5K |
271,108 |
| 2025-11-25 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
1,500 |
$70.00 |
$105K |
196,371 |
| 2025-11-14 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
2,000 |
$65.00 |
$130K |
197,871 |
| 2025-11-13 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
100 |
$64.52 |
$6.45K |
1,272,987 |
| 2025-11-11 |
Henderson Jane |
Chief Financial Officer |
Informative Sell |
1,000 |
$60.00 |
$60K |
199,871 |
| 2025-11-05 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
8,060 |
$22.86 |
$184.25K |
153,565 |
| 2025-10-10 |
Shah Nimish P |
Director |
Informative Buy |
365,853 |
- |
- |
365,853 |
| 2025-10-01 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
2,385 |
$22.86 |
$54.52K |
161,625 |
| 2025-09-03 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
190 |
$38.55 |
$7.32K |
233,548 |
| 2025-08-06 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
2,725 |
$37.78 |
$102.95K |
236,273 |
| 2025-07-02 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
7,365 |
$22.86 |
$168.36K |
164,010 |
| 2025-06-17 |
Jones William A Jr |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Shah Nimish P |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Mckenna Mark C. |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fairmount Funds Management Llc |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Fox Jennifer A. |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Gottesdiener Andrew |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-17 |
Bollinger Lisa |
Director |
RSU Award |
14,461 |
$41.66 |
$602.45K |
14,461 |
| 2025-06-04 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
2,725 |
$36.96 |
$100.72K |
241,723 |
| 2025-05-07 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
2,725 |
$35.75 |
$97.42K |
244,448 |
| 2025-04-02 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
889 |
$37.59 |
$33.42K |
247,173 |
| 2025-03-05 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
2,674 |
$30.62 |
$81.88K |
1,292,987 |
| 2025-03-05 |
Dambkowski Carl |
Chief Medical Officer |
Informative Sell |
1,590 |
$30.48 |
$48.46K |
251,033 |
| 2025-02-05 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
15,000 |
$40.58 |
$608.7K |
1,302,987 |
| 2025-02-05 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
795 |
$22.86 |
$18.17K |
171,375 |
| 2025-01-31 |
Henderson Michael Thomas |
Chief Executive Officer |
Option Exercise (Sell) |
8,500 |
$22.86 |
$194.31K |
390,012 |
| 2025-01-08 |
Henderson Michael Thomas |
Chief Executive Officer |
Informative Sell |
2,868 |
$49.38 |
$141.62K |
1,309,487 |
| 2025-01-02 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
1,360 |
$22.86 |
$31.09K |
172,170 |
| 2024-12-12 |
Mckenna Mark C. |
Director |
Informative Buy |
7,500 |
$49.02 |
$367.65K |
7,500 |
| 2024-12-11 |
Dambkowski Carl |
Chief Medical Officer |
Option Exercise (Sell) |
1,815 |
$22.86 |
$41.49K |
173,530 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
